These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

435 related articles for article (PubMed ID: 30500849)

  • 1. Co-infection with feline retrovirus is related to changes in immunological parameters of cats with sporotrichosis.
    de Miranda LHM; Meli M; Conceição-Silva F; Novacco M; Menezes RC; Pereira SA; Sugiarto S; Dos Reis ÉG; Gremião IDF; Hofmann-Lehmann R
    PLoS One; 2018; 13(11):e0207644. PubMed ID: 30500849
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Clinical features, fungal load, coinfections, histological skin changes, and itraconazole treatment response of cats with sporotrichosis caused by Sporothrix brasiliensis.
    de Souza EW; Borba CM; Pereira SA; Gremião IDF; Langohr IM; Oliveira MME; de Oliveira RVC; da Cunha CR; Zancopé-Oliveira RM; de Miranda LHM; Menezes RC
    Sci Rep; 2018 Jun; 8(1):9074. PubMed ID: 29899416
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Parameters of disease progression in long-term experimental feline retrovirus (feline immunodeficiency virus and feline leukemia virus) infections: hematology, clinical chemistry, and lymphocyte subsets.
    Hofmann-Lehmann R; Holznagel E; Ossent P; Lutz H
    Clin Diagn Lab Immunol; 1997 Jan; 4(1):33-42. PubMed ID: 9008278
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Detection of serum antibodies against Bartonella species in cats with sporotrichosis from Rio de Janeiro, Brazil.
    Kitada AA; Favacho AR; Oliveira RV; Pessoa AA; Gomes R; Honse CO; Gremião ID; Lemos ER; Pereira SA
    J Feline Med Surg; 2014 Apr; 16(4):308-11. PubMed ID: 24127458
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Recombinant FeLV vaccine: long-term protection and effect on course and outcome of FIV infection.
    Hofmann-Lehmann R; Holznagel E; Aubert A; Ossent P; Reinacher M; Lutz H
    Vet Immunol Immunopathol; 1995 May; 46(1-2):127-37. PubMed ID: 7618252
    [TBL] [Abstract][Full Text] [Related]  

  • 6. In vivo lymphocyte tropism of feline immunodeficiency virus.
    English RV; Johnson CM; Gebhard DH; Tompkins MB
    J Virol; 1993 Sep; 67(9):5175-86. PubMed ID: 7688819
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comparison of T-cell subpopulations in cats naturally infected with feline leukaemia virus or feline immunodeficiency virus.
    Hoffmann-Fezer G; Mortelbauer W; Hartmann K; Mysliwietz J; Thefeld S; Beer B; Thum I; Kraft W
    Res Vet Sci; 1996 Nov; 61(3):222-6. PubMed ID: 8938851
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Evaluation of leukocyte ratios as survival prognostic markers in feline retrovirus infections.
    Rossi A; Proverbio D; Perego R; Baggiani L; Spada E
    Vet J; 2024 Jun; 305():106128. PubMed ID: 38754624
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Performance of 4 Point-of-Care Screening Tests for Feline Leukemia Virus and Feline Immunodeficiency Virus.
    Levy JK; Crawford PC; Tucker SJ
    J Vet Intern Med; 2017 Mar; 31(2):521-526. PubMed ID: 28158913
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Survival time and effect of selected predictor variables on survival in owned pet cats seropositive for feline immunodeficiency and leukemia virus attending a referral clinic in northern Italy.
    Spada E; Perego R; Sgamma EA; Proverbio D
    Prev Vet Med; 2018 Feb; 150():38-46. PubMed ID: 29406082
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Immunization-induced decrease of the CD4+:CD8+ ratio in cats experimentally infected with feline immunodeficiency virus.
    Lehmann R; von Beust B; Niederer E; Condrau MA; Fierz W; Aubert A; Ackley CD; Cooper MD; Tompkins MB; Lutz H
    Vet Immunol Immunopathol; 1992 Dec; 35(1-2):199-214. PubMed ID: 1363009
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Toxoplasma gondii, Dirofilaria immitis, feline immunodeficiency virus (FIV), and feline leukemia virus (FeLV) infections in stray and pet cats (Felis catus) in northwest China: co-infections and risk factors.
    Cong W; Meng QF; Blaga R; Villena I; Zhu XQ; Qian AD
    Parasitol Res; 2016 Jan; 115(1):217-23. PubMed ID: 26362646
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Early events in the immunopathogenesis of feline retrovirus infections.
    Tompkins MB; Nelson PD; English RV; Novotney C
    J Am Vet Med Assoc; 1991 Nov; 199(10):1311-5. PubMed ID: 1666073
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comparison of three feline leukaemia virus (FeLV) point-of-care antigen test kits using blood and saliva.
    Westman ME; Malik R; Hall E; Sheehy PA; Norris JM
    Comp Immunol Microbiol Infect Dis; 2017 Feb; 50():88-96. PubMed ID: 28131385
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Feline leukaemia virus (FeLV) and feline immunodeficiency virus infections in cats in the Pisa district of Tuscany, and attempts to control FeLV infection in a colony of domestic cats by vaccination.
    Bandecchi P; Dell'Omodarme M; Magi M; Palamidessi A; Prati MC
    Vet Rec; 2006 Apr; 158(16):555-7. PubMed ID: 16632529
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Progressive and regressive infection with feline leukemia virus (FeLV) in cats in southern Brazil: Prevalence, risk factors associated, clinical and hematologic alterations.
    Biezus G; Grima de Cristo T; da Silva Casa M; Lovatel M; Vavassori M; Brüggemann de Souza Teixeira M; Miletti LC; Maciel da Costa U; Assis Casagrande R
    Prev Vet Med; 2023 Jul; 216():105945. PubMed ID: 37209619
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Evaluation of in vivo and in vitro interactions of feline immunodeficiency virus and feline leukemia virus.
    Beebe AM; Faith TG; Sparger EE; Torten M; Pedersen NC; Dandekar S
    AIDS; 1994 Jul; 8(7):873-8. PubMed ID: 7946095
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Epidemiology of Pathogenic Retroviruses and Domestic Cat Hepadnavirus in Community and Client-Owned Cats in Hong Kong.
    Beatty JA; Choi YR; Nekouei O; Woodhouse FM; Gray JJ; Hofmann-Lehmann R; Barrs VR
    Viruses; 2024 Jan; 16(2):. PubMed ID: 38399943
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Tumor necrosis factor alpha levels in cats experimentally infected with feline immunodeficiency virus: effects of immunization and feline leukemia virus infection.
    Lehmann R; Joller H; Haagmans BL; Lutz H
    Vet Immunol Immunopathol; 1992 Dec; 35(1-2):61-9. PubMed ID: 1337403
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Feline leukemia virus infection as a potentiating cofactor for the primary and secondary stages of experimentally induced feline immunodeficiency virus infection.
    Pedersen NC; Torten M; Rideout B; Sparger E; Tonachini T; Luciw PA; Ackley C; Levy N; Yamamoto J
    J Virol; 1990 Feb; 64(2):598-606. PubMed ID: 2153226
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 22.